Enlivex Therapeutics is trading 12.1% down at $1.98 today as investors react to a $400 million private placement funded with crypto tokens.
- The selloff, which began on July 28, follows a surprise deal with a single unnamed investor that has sparked widespread dilution concerns.
- Market participants remain skeptical of the unconventional financing structure and its potential impact on the company's capital table.